Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Unconventional treatment of inoperable biliary IPMN with an oesophageal stent in the common bile duct: case report

Siiki, Antti; Antila, Anne; Vaalavuo, Yrjö; Ronkainen, Johanna; Rinta-Kiikka, Irina; Laukkarinen, Johanna (2023)

 
Avaa tiedosto
siiki-et-al-2023-unconventional-treatment-of-inoperable-biliary-ipmn-with-an-oesophageal-stent-in-the-common-bile-duct.pdf (252.7Kt)
Lataukset: 



Siiki, Antti
Antila, Anne
Vaalavuo, Yrjö
Ronkainen, Johanna
Rinta-Kiikka, Irina
Laukkarinen, Johanna
2023

Therapeutic Advances in Gastrointestinal Endoscopy
doi:10.1177/26317745231183311
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202308297850

Kuvaus

Non peer reviewed
Tiivistelmä
<p>Biliary intraductal papillary mucinous neoplasm (IPMN) is a rare biliary neoplasia preferably treated with oncologic resection. Endoscopic radio frequency (RF) ablation may be used as a palliative measure. We present a rare case, where heavy co-morbidities prevented surgery. Continuous mucus production caused recurrent episodes of severe cholangitis. Several ERCPs (endoscopic retrograde cholangio pancretography) were necessary due to recurrent biliary obstruction. RF ablation was not effective in the dilated common bile duct without a stricture. Standard biliary stents failed due to either migration or occlusion. When other options failed, an exceptional decision was made: a covered large diameter oesophageal stent was inserted in ERCP into the bile duct to secure bile flow and stop mucus production. Digital cholangioscopy was crucial adjunct to standard ERCP in endoscopic management. The palliative treatment method was successful: there were no stent-related adverse events or readmissions for cholangitis. The follow-up in the palliative care lasted until patient’s last 10 months of lifetime.</p>
Kokoelmat
  • TUNICRIS-julkaisut [20263]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste